Table 1.

Clinical information of 90 patients with LUSC.

Parameter	Total [cases (%)]	THOC3 Expression [cases (%)]		P value
		Lowa	Higha
Total	90	12 (13.3%)	78 (86.7%)
Gender
Male	87 (96.7%)	12 (100.0%)	75 (96.2%)	0.490
Female	3 (3.3%)	0 (0.0%)	3 (3.3%)
Age at surgery (years)
≥65	57 (63.3%)	8 (66.7%)	49 (62.8%)	0.797
<65	33 (36.7%)	4 (33.3%)	29 (37.2%)
Grade
High	5 (5.6%)	1 (8.3%)	4 (5.1%)	0.520
Middle and Low	85 (94.4%)	11 (91.7%)	74 (94.9%)
Pathological stage
I	25 (27.8%)	3 (25.0%)	22 (28.2%)	0.817
II–IV	65 (72.2%)	9 (75.0%)	56 (71.8%)
Tumor size (cm)
<4	38 (42.2%)	3 (25.0%)	35 (44.9%)	0.194
≥4	52 (57.8%)	9 (75.0%)	43(55.1%)
Lymph node metastasis
Absent	49 (54.4%)	6 (50.0%)	43 (55.1%)	0.765
Present	41 (45.6%)	6 (50.0%)	35 (44.9%)

^aLow: H-score ≤ 50; High: H-score > 50.